PMDA drug package insert
パルミコート100µgタービュヘイラー112吸入
PMDA Prescription drug · アストラゼネカ株式会社 · package insert Feb 3, 2025
Key facts
| Brand names | パルミコート100µgタービュヘイラー112吸入, パルミコート200µgタービュヘイラー56吸入, パルミコート200µgタービュヘイラー112吸入 |
|---|---|
| Nonproprietary names | ブデソニド |
| Companies | 製造販売元／アストラゼネカ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ドライパウダー吸入式ステロイド薬 |
| Therapeutic category codes | 87229 |
| YJ codes | 2290701G1039, 2290701G2035, 2290701G3031 |
| Approval numbers | 21900AMX00008, 21900AMX00010, 21900AMX00009 |
| Package insert edition | 第2版 |
| Package insert date | Feb 3, 2025 |
| PMDA document key | 670227_2290701G1039_1 |
| PMDA company code | 670227 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: